Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.04. | XFRA JC4: WIEDERAUFNAHME/RESUMPTION | 140 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
08.04. | Universal Ibogaine Inc: Universal Ibogaine reinstated for trading | 7 | Stockwatch | ||
04.04. | Universal Ibogaine Inc: Universal Ibogaine to issue 4.2 million shares for debt | 16 | Stockwatch | ||
03.04. | Universal Ibogaine Inc.: Universal Ibogaine Advises of Debt Settlement Agreement and Update on Status of Cease Trade Order | 12 | TheNewswire | ||
06.02. | Universal Ibogaine Inc: Universal Ibogaine still working on 2024 financials | 36 | Stockwatch | ||
UNIVERSAL IBOGAINE Aktie jetzt für 0€ handeln | |||||
06.02. | Universal Ibogaine Inc.: Universal Ibogaine Provides Update on Status of Current Cease Trade Order | 7 | TheNewswire | ||
04.02. | XFRA JC4: AUSSETZUNG/SUSPENSION | 295 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILUNIVERSAL IBOGAINE... ► Artikel lesen | |
04.02. | Universal Ibogaine Inc: Universal Ibogaine halted at the open | 6 | Stockwatch | ||
28.01. | Universal Ibogaine Inc.: Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings | 10 | TheNewswire | ||
28.01. | Universal Ibogaine Inc: Universal Ibogaine hopes to file F2024 results in Feb. | 10 | Stockwatch | ||
22.01. | Universal Ibogaine Inc: Universal Ibogaine closes sale of Belize property | 8 | Stockwatch | ||
22.01. | Universal Ibogaine Inc: Universal Ibogaine sale of Universal Ibogaine | 10 | Stockwatch | ||
22.01. | Universal Ibogaine Inc.: Universal Ibogaine Announces Closing of Sale of Belize Property | 2 | TheNewswire | ||
14.01. | Universal Ibogaine Inc: Universal Ibogaine further delays FY 2024 results | 12 | Stockwatch | ||
14.01. | Universal Ibogaine Inc.: Universal Ibogaine Provides Bi-weekly Status Report on Year-end Filings and update on Belize Property Sale | 3 | TheNewswire | ||
28.12.24 | Universal Ibogaine Inc: Universal Ibogaine has no material changes | 19 | Stockwatch | ||
28.12.24 | Universal Ibogaine Inc.: Universal Ibogaine Provides Bi-Weekly Default Status Report on Year-End Filings and Update on Belize Property Sale | 5 | TheNewswire | ||
12.12.24 | Universal Ibogaine Inc.: Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings and update on pending sale of Belize property | 20 | TheNewswire |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SANOFI | 89,11 | +0,01 % | Milliarden-Übernahme: Sanofi kauft sich mit 9,1 Milliarden US-Dollar in US-Biotech-Markt ein! | © Foto: Martin Joppen / SanofiDer französische Pharmariese Sanofi kündigt milliardenschweren Übernahme von Blueprint Medicines an. Die Ankündigung lässt die Aktie in die Höhe steigen!Der französische... ► Artikel lesen | |
CANOPY GROWTH | 1,498 | +0,67 % | Canopy Growth has price target chopped at Roth | ||
ASTRAZENECA | 127,95 | +0,63 % | Buy or Goodbye?: Rheinmetall, LVMH, Nike und Astrazeneca - Die Analystenstimmen des Tages | © Foto: Marcus Brandt/dpaRheinmetall, LVMH, Nike und Astrazeneca: So bewerten Top-Analysten die Aktien. Ein Überblick.JPMorgan stuft Rheinmetall auf "Overweight" Die US-Bank JPMorgan hat die Einstufung... ► Artikel lesen | |
INNOCAN PHARMA | 0,111 | +2,31 % | Unglaubliche Prognose für Montag setzt Innocan Pharma Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
IONIS PHARMACEUTICALS | 30,650 | +0,46 % | Ionis Pharmaceuticals, Inc.: Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. | - Agreement enables olezarsen to reach people living with conditions associated with elevated triglycerides across the world - - Ionis will continue to independently commercialize TRYNGOLZA (olezarsen)... ► Artikel lesen | |
ROCKET LAB | 25,440 | +0,28 % | Newsflash: Rocket Lab Makes Spy Satellites Now | ||
HAPPY BELLY FOOD GROUP | 0,665 | -2,21 % | Happy Belly Food Group Inc.: Happy Belly Food Group's Smash Burger Brand Rosie's Burgers Announces the Opening of Its Newest Location in Hamilton, Ontario | Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is... ► Artikel lesen | |
CSPC PHARMA | 0,988 | +1,58 % | Dividendenbekanntmachungen (04.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADESSO SE DE000A0Z23Q5 - 0,75 EUR AGEAS SA/NV BE0974264930 - 2 EUR AIR LEASE CORPORATION US00912X3026 0,22 USD 0,1934 EUR ANALOG... ► Artikel lesen | |
ALTIMMUNE | 5,060 | +2,70 % | Citizens JMP behält Altimmune-Aktienbewertung mit Kursziel von 25 US-Dollar bei | ||
CATALYST PHARMACEUTICALS | 22,750 | +0,22 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer | CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of William (Will) T. Andrews, MD, FACP... ► Artikel lesen | |
AVADEL PHARMACEUTICALS | 8,500 | -0,58 % | Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia | DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM... ► Artikel lesen | |
NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA LR23: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUMINUS WELLNESS... ► Artikel lesen | |
ONO PHARMACEUTICAL | 9,300 | +1,09 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
ELANCO ANIMAL HEALTH | 12,158 | -0,43 % | Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief | The first-of-its-kind report includes results from multiple surveys revealing just how badly dogs around the country are itching for relief.Data reveals that nearly 9 in 10 dogs in the U.S. are "itchy... ► Artikel lesen | |
IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports First Quarter 2025 Financial Results | NEW YORK and TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen |